Liquidia Corporation $LQDA Stock: Profund Advisors LLC Raises Position

Profund Advisors LLC grew its stake in Liquidia Corporation (NASDAQ:LQDA) by 226.3% in the 3rd quarter, Holdings Channel.com reports. The firm owned 25,572 shares of the company’s stock after purchasing an additional 17,736 shares during the period. Profund Advisors LLC’s holdings in Liquidia were worth $774,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bank of New York Mellon Corp bought a new position in shares of Liquidia during the 2nd quarter valued at approximately $29,694,000. Bank of America Corp DE boosted its stake in Liquidia by 18.7% during the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after buying an additional 360,372 shares during the period. Eversept Partners LP increased its position in Liquidia by 33.0% during the first quarter. Eversept Partners LP now owns 677,392 shares of the company’s stock valued at $25,565,000 after acquiring an additional 167,949 shares during the last quarter. Seven Fleet Capital Management LP boosted its stake in shares of Liquidia by 124.5% during the 1st quarter. Seven Fleet Capital Management LP now owns 204,876 shares of the company’s stock worth $7,732,000 after purchasing an additional 113,609 shares during the period. Finally, LGT Fund Management Co Ltd. purchased a new stake in Liquidia in the 1st quarter worth about $4,161,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Liquidia Price Performance

LQDA stock opened at $47.38 on Thursday. The business has a fifty day moving average of $51.43 and a two-hundred day moving average of $54.38. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. Liquidia Corporation has a 52-week low of $22.31 and a 52-week high of $93.61. The stock has a market cap of $4.24 billion, a price-to-earnings ratio of 30.80, a price-to-earnings-growth ratio of 0.37 and a beta of 0.40.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). The business had revenue of $171.68 million for the quarter, compared to analyst estimates of $168.48 million. Liquidia had a return on equity of 149.65% and a net margin of 30.74%. The firm’s revenue for the quarter was up 1842.1% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.49) EPS. As a group, research analysts anticipate that Liquidia Corporation will post 2.05 earnings per share for the current year.

Insider Transactions at Liquidia

In other news, CEO Roger Jeffs sold 32,744 shares of the stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $28.48, for a total value of $932,549.12. Following the sale, the chief executive officer directly owned 1,125,848 shares in the company, valued at $32,064,151.04. This represents a 2.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katherine Rielly-Gauvin sold 36,789 shares of the firm’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $74.99, for a total value of $2,758,807.11. Following the sale, the director owned 44,637 shares in the company, valued at $3,347,328.63. This trade represents a 45.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 566,579 shares of company stock valued at $25,746,120 in the last three months. Insiders own 25.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on LQDA shares. HC Wainwright raised their target price on shares of Liquidia from $58.00 to $65.00 and gave the company a “buy” rating in a research report on Thursday, October 15th. Royal Bank Of Canada set a $65.00 price target on shares of Liquidia in a research note on Thursday, October 15th. Piper Sandler set a $129.00 price objective on shares of Liquidia in a report on Friday, July 24th. Raymond James Financial reaffirmed an “outperform” rating on shares of Liquidia in a research report on Thursday, October 8th. Finally, Stephens set a $130.00 price objective on Liquidia in a report on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $72.85.

Liquidia Profile

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.